Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.
- Published In:
- International journal of environmental research and public health, 19(4) (2022)
- Database ID:
- RPEP-06269
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06269APA
Kruszewska, Jagoda; Laudy-Wiaderny, Hanna; Kunicki, Michał. (2022). Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.. International journal of environmental research and public health, 19(4). https://doi.org/10.3390/ijerph19042099
MLA
Kruszewska, Jagoda, et al. "Review of Novel Potential Insulin Resistance Biomarkers in PCOS Patients-The Debate Is Still Open.." International journal of environmental research and public health, 2022. https://doi.org/10.3390/ijerph19042099
RethinkPeptides
RethinkPeptides Research Database. "Review of Novel Potential Insulin Resistance Biomarkers in P..." RPEP-06269. Retrieved from https://rethinkpeptides.com/research/kruszewska-2022-review-of-novel-potential
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.